1. Triggering and resolution of inflammation in NASH;Schuster;Nat. Rev. Gastroenterol. Hepatol.,2018
2. Leucine aminopeptidase 3:a promising serum biomarker candidate for nonalcoholic steatohepatitis diagnosis;Feng;Int. Immunopharmacol.,2023
3. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH);Xu;Signal Transduct. Target. Ther.,2022
4. Non-Alcoholic Steatohepatitis (NASH) – A Review of a Crowded Clinical Landscape;Fraile;Driven by a Complex Disease, Drug Design, Development and Therapy,2021
5. Determinants of fibrosis progression and regression in NASH;Schuppan;J. Hepatol.,2018